Evotec and Celgene enter into strategic oncology partnership
Evotec announced that Evotec and Celgene have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology. Evotec will receive an upfront payment of $65 m and may receive milestone payments and tiered royalties.
May 21, 2018